首页> 外文OA文献 >Effect of antimicrobial therapy on progression free survival of patients with non-small-cell lung cancer receiving checkpoint-inhibitor- and chemotherapy

【2h】

Effect of antimicrobial therapy on progression free survival of patients with non-small-cell lung cancer receiving checkpoint-inhibitor- and chemotherapy

机译：抗菌治疗对非小细胞肺癌接受检查点抑制剂和化疗的患者进展自由生存的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mark Uhlenbruch; Stefan Krüger;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy [J] . DasM., RiessJ.W., FrankelP., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2012,第2期

机译：使用新型检测平台的循环肿瘤细胞（CTC）中的ERCC1表达与接受铂类化疗的转移性非小细胞肺癌（NSCLC）患者的无进展生存期（PFS）相关
2. Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy [J] . Kotake Mie, Miura Yosuke, Imai Hisao, Chemotherapy: International Journal of Experimental and Clinical Chemotherapy . 2017,第4期

机译：患有先进的非小细胞肺癌患者整体存活后生存期接受多西紫杉醇单药治疗的二线化疗
3. Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapy [J] . Walzer Stefan, Chouaid Christos, Lister Johanna, Expert review of anticancer therapy . 2015,第1期

机译：非鳞状非小细胞肺癌序贯治疗患者无进展生存期的模拟和比较
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Impact of EGFR mutation status on tumor response and progression free survival after first-line chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis [O] . Wenhua Liang, Yaxiong Zhang, Shiyang Kang, 2014

机译：EGFR突变状态对晚期非小细胞肺癌一线化疗后肿瘤反应和无进展生存的影响：荟萃分析
7. The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis [O] . Xinyi Li, Cong Huang, Xiaohui Xie, 2020

机译：吸烟状态对接受分子靶疗法或免疫疗法的非小细胞肺癌患者的无进展存活的影响与化疗：荟萃分析

Effect of antimicrobial therapy on progression free survival of patients with non-small-cell lung cancer receiving checkpoint-inhibitor- and chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅